|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2007-10-4
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Agitation is a common and distressing symptom in patients with Alzheimer's disease. Cholinesterase inhibitors improve cognitive outcomes in such patients, but the benefits of these drugs for behavioral disturbances are unclear.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:BallardClive GCG,
pubmed-author:BenthamPeterP,
pubmed-author:BrownRichard GRG,
pubmed-author:BullockRogerR,
pubmed-author:BurnsAlistair SAS,
pubmed-author:CALM-AD Trial Group,
pubmed-author:DeCesareJuliaJ,
pubmed-author:HolmesCliveC,
pubmed-author:HowardRobert JRJ,
pubmed-author:JacobyRobinR,
pubmed-author:JohnsonTonyT,
pubmed-author:JonesRoy WRW,
pubmed-author:JuszczakEdmundE,
pubmed-author:KatonaCorneliusC,
pubmed-author:KnappMartinM,
pubmed-author:LindesayJamesJ,
pubmed-author:O'BrienJohn TJT,
pubmed-author:RodgerMichaelaM,
pubmed-author:WilcockGordonG
|
|
pubmed:copyrightInfo |
Copyright 2007 Massachusetts Medical Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
4
|
|
pubmed:volume |
357
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1382-92
|
|
pubmed:dateRevised |
2008-8-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17914039-Aged,
pubmed-meshheading:17914039-Aged, 80 and over,
pubmed-meshheading:17914039-Alzheimer Disease,
pubmed-meshheading:17914039-Cholinesterase Inhibitors,
pubmed-meshheading:17914039-Double-Blind Method,
pubmed-meshheading:17914039-Female,
pubmed-meshheading:17914039-Humans,
pubmed-meshheading:17914039-Indans,
pubmed-meshheading:17914039-Male,
pubmed-meshheading:17914039-Piperidines,
pubmed-meshheading:17914039-Psychomotor Agitation,
pubmed-meshheading:17914039-Psychotherapy,
pubmed-meshheading:17914039-Social Support,
pubmed-meshheading:17914039-Treatment Failure
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Donepezil for the treatment of agitation in Alzheimer's disease.
|
|
pubmed:affiliation |
Medical Research Council Neurogeneration Research Centre, Institute of Psychiatry, King's College London, London, United Kingdom. robert.howard@iop.kcl.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
